Orosomucoid 2 (ORM2) in type 2 diabetes and coronary artery disease: a potential link between insulin resistance and vascular inflammation - Top-Institutions - MDSpire

Orosomucoid 2 (ORM2) in type 2 diabetes and coronary artery disease: a potential link between insulin resistance and vascular inflammation

  • By

  • Xia Sun

  • Xiang Tang

  • Guoyue Yuan

  • June 25, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Cardiology

  • #2

    NewYork-Presbyterian Hospital/Columbia University Irving Medical Center
    NewYork-Presbyterian Hospital/Columbia University Irving Medical Center

    New York, New York

    Key Differentiators

    • Endocrinology
    • Cardiology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology
    • Cardiology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Endocrinology
    • Cardiology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Cardiology

Original Source(s)

Orosomucoid 2 (ORM2) in type 2 diabetes and coronary artery disease: a potential link between insulin resistance and vascular inflammation

  • by Xia Sun, Xiang Tang, Guoyue Yuan

  • June 25, 2026

Related Content

Parents’ history of hypertension, diabetes, and dyslipidemia with offspring cardiac damage – a 24-year longitudinal study

SNAP bans on soda, candy and other foods take effect in five states Jan. 1

California considers seal of approval for foods that are not ultra-processed